JUL 24, 2018 01:24 PM PDT

The Chili Pepper Drug Aims To Combat Obesity

WRITTEN BY: Nouran Amin

A new drug was recently developed based on capsaicin, the compound found in chili peppers that is responsible for their spicy properties, was seen to cause long-term weight loss and improve metabolic health in mice ingesting a high-fat diet. According to studies at the University of Wyoming School of Pharmacy, the drug, now called Metabocin, was created to release capsaicin slowly during the day in order to exert anti-obesity effects without adverse side-effects. "We observed marked improvements in blood sugar and cholesterol levels, insulin response, and symptoms of fatty liver disease," explained lead investigator Dr. Baskaran Thyagarajan. The results of the research study were presented at the annual meeting of the Society for the Study of Ingestive Behavior, an international conference led by experts on food and fluid intake. The results concluded that Metabocin reversed the damaging effects of a high-fat diet.

Watch Video Below To Understand More About The Science of Spiciness:

Metabocin was developed to be taken orally and to target specific receptors found on fat cells. These particular receptors are called TRPV1 (transient receptor potential vanilloid subfamily 1) and when stimulated lead to white fat cells to start to burn the accumulated energy instead of storing that energy. This process, in theory, is believed to cause weight loss. However, an important question remained for researchers if Metabocin remained effective when administered long-term and if any adverse effects would outweigh the benefits. So, the experimental mice remained on the drug for 8 months and the results showed that weight loss was maintained with no evidence of safety issues. There are more experiments planned to see how long that weight loss can be maintained, but overall the results are promising. "It proved safe and was well tolerated by the mice," Thyagarajan concluded. "Developing Metabocin as a potent anti-obesity treatment shows promise as part of a robust strategy for helping people struggling with obesity."

The research study might give the idea that ingesting spicy foods will encourage weight loss, however, biochemically speaking it might not always work since most of the capsaicin present in the food is not well absorbed by the body. Metabocin was designed to carry a modified version of the capsaicin so it can be easily absorbed.

Source: Society for the Study of Ingestive Behavior

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 15, 2019
Genetics & Genomics
OCT 15, 2019
Combination Therapy Eliminates HIV From Rodent Model
In 2017, 1.8 million new cases of HIV infection were diagnosed around the world, and around 37 million people live with the virus....
OCT 15, 2019
Drug Discovery & Development
OCT 15, 2019
HIV Therapeutics Places Risk of Neural Tube Defects
In a study published in the New England Journal of Medicine, women taking an HIV therapeutic drug containing dolutegravir have a higher risk of giving birt...
OCT 15, 2019
Drug Discovery & Development
OCT 15, 2019
Gel Reduces Surgical Scarring
Scientists have found that spraying a gel on the internal tissues of animal post-surgery has significantly reduced scarring—which can often lead to d...
OCT 15, 2019
Cell & Molecular Biology
OCT 15, 2019
Stopping Metastasis After Breast Cancer Surgery
Cancer is most deadly when it metastasizes, which can happen after tumor-removal surgery. It's a serious challenge for many patients....
OCT 15, 2019
Drug Discovery & Development
OCT 15, 2019
Injectable Hydrogel Found Safe for Heart Repair
The first successful in-human clinical trial of an injectable hydrogel that aims to repair heart damage and restore cardiac function was recently conducted...
OCT 15, 2019
Drug Discovery & Development
OCT 15, 2019
Peptide-Based Therapeutics Advances Alzheimer Disease Research
Affecting 44 million individuals globally, Alzheimer’s disease (AD) is a form of dementia characterized by loss of brain cells, inflammation and vasc...
Loading Comments...